StockWatch
·
Pharmaceuticals
Acquisitions8 Jun 2026, 12:45 pm

Viyash Scientific Acquires Italy's BioForLife for ~₹188 Cr

AI Summary

Viyash Scientific Limited, through its subsidiary Alivira Animal Health Limited, has agreed to acquire 100% of BioForLife Italia S.r.l. (BFL) for approximately ₹188 crore. This acquisition marks a strategic entry into Italy's companion animal health market, one of Europe's largest. BFL specializes in pet care products, including nutritional complements, pharmaceuticals, and diagnostic tests, with strong reach to veterinary clinics. The deal is expected to close in Q2 FY27 and is anticipated to accelerate Viyash's global pet care growth by expanding Alivira's European presence and providing a platform for new product launches.

Key Highlights

  • Viyash Scientific acquires Italian pet care firm BioForLife for ~₹188 crore.
  • Acquisition strengthens European companion animal health market presence.
  • Expected to close in Q2 FY27, accelerating global pet care growth.
  • BioForLife has a strong product portfolio and reaches over 80% of Italian vet clinics.
  • Transaction aligns with Viyash's strategy to build a leading global companion animal health business.